A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer.

Kathleen M MooreDavid S HongManish R PatelShubham PantSusanna V UlahannanSuzanne JonesFunda Meric-BernstamJudy S WangRaid AljumailyErika P HamiltonErika S WittchenXuejing WangAimee Bence LinJohanna C Bendell

Published in: Targeted oncology (2021)

NCT02124148 (date of registration 28 April 2014).

Keyphrases

papillary thyroid
healthcare
squamous cell carcinoma
small cell lung cancer
palliative care
study protocol
squamous cell
clinical trial
phase iii
quality improvement
phase ii
lymph node metastasis
randomized controlled trial
pain management
affordable care act
health insurance